Literature DB >> 17961028

Nelson syndrome: comprehensive review of pathophysiology, diagnosis, and management.

Magdalena J Banasiak1, Ali R Malek.   

Abstract

Nelson syndrome (NS) is a rare clinical manifestation of an enlarging pituitary adenoma that can occur following bilateral adrenal gland removal performed for the treatment of Cushing disease. It is characterized by excess adreno-corticotropin secretion and hyperpigmentation of the skin and mucus membranes. The authors present a comprehensive review of the pathophysiology, diagnosis, and management of NS. Corticotroph adenomas in NS remain challenging tumors that can lead to significant rates of morbidity and mortality. A better understanding of the natural history of NS, advances in neurophysiology and neuroimaging, and growing experience with surgical intervention and radiation have expanded the repertoire of treatments. Currently available treatments include surgical, radiation, and medical therapy. Although the primary treatment for each tumor type may vary, it is important to consider all of the available options and select the one that is most appropriate for the individual case, particularly in cases of lesions resistant to intervention.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17961028     DOI: 10.3171/foc.2007.23.3.15

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  10 in total

Review 1.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

2.  Low immunohistochemical expression of MGMT in ACTH secreting pituitary tumors of patients with Nelson syndrome.

Authors:  Fateme Salehi; Bernd W Scheithauer; Veronica J Moyes; William M Drake; Luis V Syro; Branavan Manoranjan; Soniya Sharma; Eva Horvath; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2010-12       Impact factor: 3.943

Review 3.  Aggressive pituitary adenomas--diagnosis and emerging treatments.

Authors:  Antonio Di Ieva; Fabio Rotondo; Luis V Syro; Michael D Cusimano; Kalman Kovacs
Journal:  Nat Rev Endocrinol       Date:  2014-05-13       Impact factor: 43.330

4.  Nelson's syndrome presenting as bilateral oculomotor palsy.

Authors:  Abhay Gundgurthi; Sandeep Kharb; M K Garg; K S Brar; Reena Bharwaj; H C Pathak; Maneet Gill
Journal:  Indian J Endocrinol Metab       Date:  2013-11

5.  Aggressive Pituitary Macroadenoma Treated With Capecitabine and Temozolomide Chemotherapy Combination in a Patient With Nelson's Syndrome: A Case Report.

Authors:  Oriol Mirallas; Francesca Filippi-Arriaga; Irene Hernandez Hernandez; Anton Aubanell; Anas Chaachou; Alejandro Garcia-Alvarez; Jorge Hernando; Elena Martínez-Saez; Betina Biagetti; Jaume Capdevila
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-11       Impact factor: 5.555

Review 6.  Aggressive Cushing's Disease: Molecular Pathology and Its Therapeutic Approach.

Authors:  Masaaki Yamamoto; Takahiro Nakao; Wataru Ogawa; Hidenori Fukuoka
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-16       Impact factor: 5.555

7.  Diagnosis and Multimodality Management of Cushing's Disease: A Practical Review.

Authors:  Gabriel Zada
Journal:  Int J Endocrinol       Date:  2013-01-15       Impact factor: 3.257

8.  Positron emission tomography-computed tomography coregistration for diagnosis and intraoperative localization in recurrent nelson syndrome.

Authors:  Eric B Hintz; Jeffery M Tomlin; Vaseem Chengazi; G Edward Vates
Journal:  J Neurol Surg Rep       Date:  2013-05-09

9.  Leksell Gamma Knife : An Effective Non Invasive Treatment for Rare Case of Nelson's Syndrome.

Authors:  Faheem Arshad; Bashir Ahmad Laway; Manzoor Ahmad Bhat; Hakim Irfan Showkat; Suman Kotwal; Shahnaz Ahmad Mir
Journal:  Int J Endocrinol Metab       Date:  2013-07-01

10.  Prevalence of Nelson's syndrome after bilateral adrenalectomy in patients with cushing's disease: a systematic review and meta-analysis.

Authors:  Eleni Papakokkinou; Marta Piasecka; Hanne Krage Carlsen; Dimitrios Chantzichristos; Daniel S Olsson; Per Dahlqvist; Maria Petersson; Katarina Berinder; Sophie Bensing; Charlotte Höybye; Britt Edén Engström; Pia Burman; Cecilia Follin; David Petranek; Eva Marie Erfurth; Jeanette Wahlberg; Bertil Ekman; Anna-Karin Åkerman; Erik Schwarcz; Gudmundur Johannsson; Henrik Falhammar; Oskar Ragnarsson
Journal:  Pituitary       Date:  2021-05-25       Impact factor: 4.107

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.